| (B) | |||||||||
| <60 years | 60–79 years | ≥80 years | |||||||
| Patients with SSc n=454 | General population n=1 020 794 | O/E ratio (95% CI) | Patients with SSc n=1473 | General population n=2 162 597 | O/E ratio (95% CI) | Patients with SSc n=792 | General population n=3 311 866 | O/E ratio (95% CI) | |
| Cardiovascular disease | 176 (38.8%) | 125 895 (12.3%) | 3.14 (2.80 to 3.53) | 576 (39.1%) | 524 385 (24.2%) | 1.61 (1.51 to 1.72) | 318 (40.1%) | 1 185 853 (35.8%) | 1.12 (1.03 to 1.22) |
| Respiratory disease | 94 (20.7%) | 22 248 (2.2%) | 9.50 (7.93 to 11.38) | 292 (19.8%) | 113 894 (5.3%) | 3.76 (3.40 to 4.17) | 120 (15.1%) | 268 580 (8.1%) | 1.87 (1.58 to 2.20) |
| Infectious disease | 56 (12.3%) | 23 135 (2.3%) | 5.44 (4.26 to 6.96) | 162 (11.0%) | 40 009 (1.8%) | 5.94 (5.14 to 6.88) | 85 (10.7%) | 65 882 (2.0%) | 5.39 (4.41 to 6.60) |
| Malignant neoplasm | 60 (13.2%) | 362 804 (35.5%) | 0.37 (0.29 to 0.47) | 135 (9.2%) | 881 509 (40.8%) | 0.22 (0.19 to 0.26) | 58 (7.3%) | 568 928 (17.2%) | 0.43 (0.33 to 0.55) |
| Gastrointestinal disease | 30 (6.6%) | 61 906 (6.1%) | 1.09 (0.77 to 1.54) | 95 (6.4%) | 102 975 (4.8%) | 1.35 (1.11 to 1.64) | 27 (3.4%) | 122 439 (3.7%) | 0.92 (0.64 to 1.34) |
Unless specified otherwise, the values are numbers (%) of observations.
O/E, observed/expected; SSC, systemic sclerosis.